Alexion Pharma (ALXN) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Investment income: 1.87M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Investment income: 1.87M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) reported Q4 EPS of $1.30, $0.02 better than the analyst estimate of $1.28. Revenue for the quarter came in at $599 million versus the consensus estimate of $590.5 million.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
